To evaluate the efficacy of CD4+ Th1-like cells in controlling tumor growth, we expanded CD4+ OT-II and CD8+ OT-I cells in vitro with the method we optimized (Supplementary Data Schema S5), and adoptively transferred them into mice bearing an established B16-OVA melanoma (Figure 5a). This evidence concerns the gene CD8A and melanoma.